SCHEMBL31000894

SCHEMBL31000894

CC[C@H](C)[C@H](NC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](CCCCN)NC(=O)CNC(=O)[C@@H]1CCCN1)C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@H](C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](C)C(=O)O)[C@@H](C)O)[C@@H](C)CC)C(C)C

nearest known ligand 0.69

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ GLP1R P43220 19/20 0.69
▸ NPY1R P25929 1/20 0.61
▸ NPY2R P49146 1/20 0.61
▸ NPY4R P50391 1/20 0.61
▸ NPY5R Q15761 1/20 0.61
▸ ECE1 P42892 1/20 0.60
▸ MUS81 Q96NY9 1/20 0.60
▸ CCKBR P32239 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30906543 0.97 GLP1R (0.64) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30906394 0.97 GLP1R (0.64) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30906370 0.95 GLP1R (0.62) GLP1RCCKBR
SCHEMBL30906359 0.95 GLP1R (0.63) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL29479845 0.94 GLP1R (0.69) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30726576 0.93 GLP1R (0.69) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL29679739 0.92 GLP1R (0.65) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL31547376 0.91 GLP1R (0.70) GLP1RNPY1RNPY2RNPY4RNPY5R
SCHEMBL30648497 0.91 GLP1R (0.64) GLP1RCCKBR
SCHEMBL31000884 0.91 NPY2R (0.75) GLP1RNPY1RNPY2RNPY4RNPY5R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630447-A2 ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF Abwiz Bio, Inc. (US) 2025-10-15 — — EP disclosed
WO-2024124241-A2 ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF ABWIZ BIO, INC. (US) 2024-06-13 — — WO disclosed
Send feedback